<img src="//tracker.clixtell.com/track/t.gif">
Skip to the main content.
Call Us Now
Call Us Now

2 min read

IVIG Treatment for GBS and CIDP

Guillain-Barre Syndrome ("GBS") is a rare disorder in which a person’s own immune system damages their nerve cells, causing muscle weakness and sometimes paralysis. Chronic inflammatory demyelinating polyneuropathy ("CIDP") is a similar inflammatory disorder of the peripheral nervous system and is considered the chronic counterpart of GBS. GBS and CIDP can be triggered by various vaccinations such as the influenza vaccine, tetanus shot, Hepatitis B vaccine, the Gardasil vaccine, and other vaccinations.

The initial symptoms of GBS are typically numbness, weakness or tingling in the legs and arms. Those sensations can spread to the arms and upper body and can sometimes develop into symptoms of paralysis. In order to diagnose individuals with GBS, doctors employ a physical examination and diagnostic tests such as a lumbar puncture and a nerve conduction study.

Individuals who are diagnosed with GBS are typically admitted to a hospital for close monitoring until it has been determined that the symptoms have plateaued.  In most cases, doctors prescribe corticosteroids, plasmapheresis (plasma exchange) and Intravenous immunoglobulin (IVIG) therapy, a proven effective treatment for GBS.

IVIG is a sterile solution of concentrated antibodies extracted from healthy donors which is administered into a vein. It is typically prepared from the serum of between 1000 and 15 000 donors per batch. The plasma from all of these individuals is pooled together and chemically treated to isolate the immune globulins and remove any other blood proteins or blood-borne pathogens. The end result is a purified immune globulin. For patients with GBS, IVIG is applied in a regimen of 2 g/kg bodyweight, usually as 0.4 g/kg bodyweight per day for five consecutive days.

Although IVIG is considered an effective treatment of GBS, prognosis is highly variable and difficult to predict: about 20% of patients are still unable to walk unaided after 6 months. Important variables associated with poor outcome are age, presence of preceding diarrhea and the severity of early symptoms.

The national vaccine attorneys at My Vaccine Lawyer have dedicated our careers to fighting for the victims of severe vaccine reactions including people who developed GBS or CIDP following a vaccination. If you believe you may have suffered an adverse reaction to a vaccine, please contact My Vaccine Lawyer at (800) 229-7704 for a free consultation.

 

Meet the Author

Paul Brazil - Founding Partner

Paul Brazil is a native of Dunmore, Pennsylvania and a graduate of Dunmore High School. For his undergraduate education, he attended Bloomsburg University where he majored in political science. He then went on to earn his JD from Widener University School of Law. Following graduation from law school, Mr. Brazil worked at a large Philadelphia civil defense firm where he litigated workers’ compensation claims and Heart and Lung Act cases. In 2012, he joined with his coworker Max Muller to form Muller Brazil. 

New call-to-action

Other posts by Paul Brazil

Max Muller Wins Landmark Vaccine Injury Case

Max Muller Wins Landmark Vaccine Injury Case

Max Muller, a vaccine injury lawyer, successfully argued in court that the Prevnar pneumonia vaccine caused Guillain-Barre Syndrome (GBS) in a...

Read More
Everything You Need to Know About a Flu Shot Lawsuit

Everything You Need to Know About a Flu Shot Lawsuit

Many people have serious concerns about the safety and efficacy of vaccines, and the flu shot is no exception. In recent years, many lawsuits have...

Read More
Chronic ITP Life Expectancy And Risks

1 min read

Chronic ITP Life Expectancy And Risks

Immune thrombocytopenic purpura (ITP) is a disorder marked by the immune system's mistaken attack on platelets, which can result in increased...

Read More